BROSHY ERAN bought TBPH
November 26, 2025 · Form 4 insider transaction
BROSHY ERAN bought 14,000 shares of Theravance Biopharma, Inc. at $10.15 per share, a transaction worth $142.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,000
Price
$10.15
Total value
$142.1K
InsiderBROSHY ERAN
RoleDirector
SecurityShare Option (Right to Buy)
Transaction codeM: Option exercise
Transaction dateNovember 26, 2025
Filing dateDecember 1, 2025
Shares owned after81,749
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This Share Option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date).; Reflects solely exercisable, vested Share Options following reported transaction.